🇺🇸 Levemir (insulin detemir) in United States

303 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 77 reports (25.41%)
  2. Nausea — 43 reports (14.19%)
  3. Weight Decreased — 38 reports (12.54%)
  4. Blood Glucose Decreased — 30 reports (9.9%)
  5. Vomiting — 25 reports (8.25%)
  6. Fatigue — 21 reports (6.93%)
  7. Decreased Appetite — 20 reports (6.6%)
  8. Drug Ineffective — 18 reports (5.94%)
  9. Headache — 17 reports (5.61%)
  10. Diarrhoea — 14 reports (4.62%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Levemir (insulin detemir) approved in United States?

Levemir (insulin detemir) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Levemir (insulin detemir) in United States?

Rabin Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.